期刊文献+

Synthesis and Crystal Structure of 4-Arylamino-6-chloropyrido[3,2-d]pyrimidine

Synthesis and Crystal Structure of 4-Arylamino-6-chloropyrido[3,2-d]pyrimidine
下载PDF
导出
摘要 The title compounds 4a~c were synthesized and characterized by IR,NMR and MS.The crystal structure of C16H13ClN4O2·HBr·H2O(I),the quaternary ammonium salt of 4c,was determined by X-ray diffraction analysis.I crystallizes in triclinic,space group P1 with a = 8.3121(8),b = 9.3885(8),c = 13.2903(12),α = 106.788(2),β = 95.204(3),γ = 110.871(2)o,V = 905.81(14)3,Z = 2,C16H16BrClN4O3,Mr = 427.68,Dc = 1.568 g/cm3,F(000) = 432.00,μ = 2.446 mm-1,R = 0.0496 and wR = 0.127.X-ray analysis reveals that C(15) in the BrCH2COOH molecule binds to the N(1) of pyrimidine ring to form the quaternary ammonium salt.Two adjacent I molecules are connected by hydrogen bonds through carboxylate oxygen,water molecule and hydrobromic acid. The title compounds 4a~c were synthesized and characterized by IR,NMR and MS.The crystal structure of C16H13ClN4O2·HBr·H2O(I),the quaternary ammonium salt of 4c,was determined by X-ray diffraction analysis.I crystallizes in triclinic,space group P1 with a = 8.3121(8),b = 9.3885(8),c = 13.2903(12),α = 106.788(2),β = 95.204(3),γ = 110.871(2)o,V = 905.81(14)3,Z = 2,C16H16BrClN4O3,Mr = 427.68,Dc = 1.568 g/cm3,F(000) = 432.00,μ = 2.446 mm-1,R = 0.0496 and wR = 0.127.X-ray analysis reveals that C(15) in the BrCH2COOH molecule binds to the N(1) of pyrimidine ring to form the quaternary ammonium salt.Two adjacent I molecules are connected by hydrogen bonds through carboxylate oxygen,water molecule and hydrobromic acid.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2010年第6期967-971,共5页 结构化学(英文)
基金 supported by the Natural Science Foundation of Zhejiang Province (No. Y4090056)
关键词 pyridopyrimidium derivatives quaternary ammonium salts crystal structure hydrogen bond pyridopyrimidium derivatives,quaternary ammonium salts,crystal structure,hydrogen bond
  • 相关文献

参考文献20

  • 1Gangjee, A.; Adair, O.; Queener, S. F. J. Med. Chem. 1999, 42, 2447-2455.
  • 2Zheng, G. Z.; Lee, C.; Pratt, J. K.; Perner, R. J.; Jiang, M. Q. Bio. & Med Chem. Lett. 2001, 11, 2071-2074.
  • 3Ei-gazzar, A. B.; Hafez, H. N. Bio. & Med. Chem. Lett. 2009, 19, 3392-3397.
  • 4Annea, L.; Grigorios, N.; Peter, S. J. US Patent, C07D, 2008227797 2008-09-18.
  • 5Elneairy, M.; Oad-Elkareem, M.; Taha, A. M. Journal of Sulfur Chemistry 2005, 26, 381-391.
  • 6Heckler, R. E.; Jourdan, G. P. Eur. Patent, C07D, 414386 1991-02-27.
  • 7Devi, I.; Borah, H. N.; Bhuyan, P. J. Tetrahedron Lett. 2004, 45, 2405-2408.
  • 8Dimitroff, C. J.; Klohs, W.; Sharma, A. Investigational New Drugs 1999, 17, 121-135.
  • 9Pascal, E; Giorgio, C.; Vito, G Bio. & Med. Chem. Lett. 2008,18,897-900.
  • 10Stephen, D. S.; Wai, J. K_; Laura, F. Journal of Neurochemistry 2002, 75, 1520-1527.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部